Skip to content
type1.science

Instinct sensor (made by Abbott, sold by MiniMed)

Abbott (manufactured) / MiniMed (sold)

Abbott builds it, MiniMed sells it: a 15-day, factory-calibrated, all-in-one sensor that ends MiniMed's reliance on its own weaker Guardian and Simplera sensors. The catch is that it stays inside MiniMed's walled garden — it drives the MiniMed 780G closed loop and the MiniMed Go smart-pen system, and nothing else. No independent accuracy study has been published yet.

Available nowRegulator-approvedcgm

The scorecard

Accuracy80

The ADA's Consumer Guide lists an overall MARD of 8.2%, which would put Instinct in the same class as the best sensors on the market. Scored a notch below Dexcom's 15-day G7 (MARD 8.0%, from a published pivotal study) because no manufacturer-independent head-to-head of Instinct has been published yet — the number is a listed spec, not an independently replicated result.[6]

Low lag65

It reads interstitial fluid like every other sensor here, so the ~10–15 minute physiological lag behind blood glucose is unchanged. No Instinct-specific lag data have been published; this is not a differentiator either way.

Interoperability35

Deliberately closed. Instinct drives only MiniMed's own hardware — the MiniMed 780G pump and the MiniMed Go smart-pen app. It does not work with Tandem, Omnipod, iLet or any open-source loop, and despite being built by Abbott it is not a FreeStyle Libre and does not work with Libre's apps. Slightly above the standalone Simplera only because it at least drives an AID system as well as a pen.[1]

Sensor lifespan88

Up to 15 days of wear — double MiniMed's own Guardian 4 and Simplera Sync (7 days and 6–7 days), and matching the longest-wearing sensors available.[4]

No calibration90

Factory-calibrated — no routine fingersticks required.[6]

Alerts & prediction75

Configurable high/low alerts through the MiniMed app, with 5-minute readings; in the MiniMed Go smart-pen system the alerts also drive missed-dose and high-glucose dosing prompts. No published head-to-head of its hypo-detection rate, so scored at the category norm rather than above it.[3]

Form factor88

A one-piece disposable sensor with no separate transmitter, marketed as the smallest and thinnest integrated CGM, with a 1-hour warm-up — faster than Simplera's 2 hours.[6]

Ketone sensing0

No ketone sensing — glucose only. Abbott's ketone work sits in its separate Libre line, not here.

Access & cost55

Genuinely purchasable on two continents — US ordering opened September 2025 with the full commercial launch in December 2025, and the EU followed with a CE Mark in March 2026 and a country-by-country rollout from June 2026. But it is only obtainable if you are already on MiniMed hardware, which is the whole limitation.[5]

Editor’s take

The most consequential thing to happen to MiniMed's sensor problem in a decade — and a reminder that "better sensor" and "open sensor" are different things. MiniMed's Achilles heel was never its algorithm, it was its sensors; buying Abbott's fixes that. But Instinct is Abbott-built and MiniMed-exclusive, so a 780G still cannot pair with a Dexcom or a retail Libre. Lock-in is broken on the supply side, not for the person wearing it. Treat the 8.2% MARD as promising-but-unaudited until someone independent puts Instinct on an arm next to a G7.

The full picture

The Instinct sensor is the sensor Abbott makes and MiniMed sells. It is a one-piece, disposable, factory-calibrated continuous glucose monitor (CGM) worn on the upper arm, with up to 15 days of wear, a 1-hour warm-up, and a reading every five minutes.1 It matters out of proportion to its spec sheet, because for years MiniMed's automated insulin delivery (AID) algorithm was well regarded while its sensors were the weak link. Instinct is MiniMed's answer: rather than fix its own sensor, it bought its rival's.

What it works with — read this before anything else. Instinct is not a consumer product you can just buy. It exists only inside MiniMed's ecosystem, and drives exactly two things: the MiniMed 780G closed loop, cleared by the FDA on 2 September 2025 (which also cleared MiniMed's SmartGuard algorithm as an interoperable automated glycemic controller, or iAGC),2 and the MiniMed Go smart-pen system for people on injections, cleared on 12 January 2026, which pairs the InPen with Instinct in a single app.3 It does not work with Tandem, Omnipod, iLet, or any open-source loop. And although Abbott builds it, it is not a FreeStyle Libre — it does not work with Libre's apps or readers. If you are not on MiniMed hardware, this sensor is not available to you at any price.

Accuracy — promising, but not yet independently checked. The American Diabetes Association's Consumer Guide lists Instinct's MARD (mean absolute relative difference — lower is better) at 8.2%, which would place it alongside the most accurate sensors on the market and far ahead of MiniMed's own Guardian 4 and Simplera.1 Two honest caveats. First, no manufacturer-independent head-to-head study of Instinct has been published — the sensors that have been independently tested against each other (Dexcom G7, FreeStyle Libre 3, Simplera) sometimes performed noticeably worse in the real world than on their spec sheets, and Instinct has not yet faced that test. Second, MiniMed says a randomized crossover study in Diabetes Technology & Therapeutics found 780G outcomes "virtually identical" whether the pump ran on Instinct or on Simplera Sync, and points to real-world data from more than 20,000 US users — but we could not locate a DOI or PMID for that study, so that is the company's account of it, not a paper we have read.4 Treat 8.2% as a credible manufacturer-side figure awaiting independent confirmation.

Wear and calibration. Up to 15 days per sensor — double the 7 days of MiniMed's Guardian 4 and the 6–7 days of Simplera Sync, and matching the longest-wearing sensors available.5 It is factory-calibrated, so no routine fingersticks, and it warms up in about an hour.1 Fewer insertions and fewer fingersticks is a real quality-of-life gain, and for a pump user it is the most tangible thing Instinct changes day to day.

Ketones. None. Instinct senses glucose only. Abbott's continuous-ketone work lives in its separate Libre line and is not part of this sensor.

Who it's for — the age rules differ by system and by continent. In the US, the 780G-with-Instinct pairing is cleared from age 7 and up; the MiniMed Go smart-pen system extends down to ages 2–6 with adult supervision.3 In the EU, the CE Mark covers ages 2 and up, and — unlike the US label — explicitly includes pregnancy.5 If you are pregnant and in the US, that indication does not apply to you.

Access. US ordering opened in September 2025 and the full US commercial launch of the 780G with Instinct followed on 2 December 2025.6 Europe got the CE Mark on 10 March 2026,5 with a country-by-country commercial rollout of Instinct and Instinct Go beginning 23 June 2026.4 So it is genuinely purchasable on two continents — but, again, only as part of MiniMed's system.

What's coming. The European rollout continues market by market through 2026, and the MiniMed Go smart-pen system is expected to broaden in the US.43 The thing worth watching for is not a new feature but an independent accuracy study: until someone puts Instinct on an arm next to a Dexcom G7 and publishes the result, its headline number remains unaudited.

References

  1. American Diabetes Association. Instinct Sensor — Consumer Guide (MARD 8.2%; 15-day wear; 1-hour warm-up; no calibration; readings every 5 minutes). https://consumerguide.diabetes.org/products/cgms/instinct-sensor ↩ ↩2 ↩3

  2. Medtronic. FDA Clears MiniMed™ 780G System to Enable Integration with the Instinct Sensor, Made by Abbott, and Approves Use in Type 2 Diabetes (Sep 2, 2025). https://news.medtronic.com/2025-09-02-FDA-Clears-MiniMed-TM-780G-System-to-Enable-Integration-with-the-Instinct-Sensor,-Made-by-Abbott,-and-Approves-Use-in-Type-2-Diabetes ↩

  3. Medtronic Diabetes. Medtronic Diabetes announces FDA clearance for MiniMed Go™ Smart MDI system featuring Instinct sensor made by Abbott (Jan 12, 2026). https://www.prnewswire.com/news-releases/medtronic-diabetes-announces-fda-clearance-for-minimed-go-smart-mdi-system-featuring-instinct-sensor-made-by-abbott-302658516.html ↩ ↩2 ↩3

  4. MiniMed. MiniMed launches Instinct sensors in Europe giving people with diabetes more sensor choice with the same proven outcomes (Jun 23, 2026). https://news.minimed.com/2026-06-23-MiniMed-launches-Instinct-sensors-in-Europe-giving-people-with-diabetes-more-sensor-choice-with-the-same-proven-outcomes ↩ ↩2 ↩3

  5. MiniMed. MiniMed expands sensor portfolio in Europe with CE Mark for MiniMed™ 780G system with the Instinct sensor, made by Abbott (Mar 10, 2026). https://news.minimed.com/2026-03-10-MiniMed-expands-sensor-portfolio-in-Europe-with-CE-Mark-for-MiniMed-TM-780G-system-with-the-Instinct-sensor,-made-by-Abbott ↩ ↩2 ↩3

  6. Drug Delivery Business. Medtronic begins full launch of MiniMed 780G with Abbott Instinct (Dec 2, 2025). https://www.drugdeliverybusiness.com/medtronic-full-launch-minimed-780g-abbott-instinct/ ↩

What's next for this

  • →Phased country-by-country European rollout of Instinct and Instinct Go continues · 2026
  • →Broader US launch of the MiniMed Go smart-pen system built around Instinct · 2026

Sources

  1. [1]FDA Clears MiniMed 780G System to Enable Integration with the Instinct Sensor, Made by Abbott, and Approves Use in Type 2 Diabetes · manufacturer · 2025-09-02 — FDA clearance (2 Sep 2025) of the MiniMed 780G to run on the Abbott-built Instinct sensor, via clearance of SmartGuard as an interoperable automated glycemic controller (iAGC). Confirms up to 15-day wear.
  2. [2]Medtronic begins full launch of MiniMed 780G with Abbott Instinct · news · 2025-12-02 — Full US commercial launch of the MiniMed 780G with Instinct on 2 Dec 2025, after ordering opened in September 2025.
  3. [3]Medtronic Diabetes announces FDA clearance for MiniMed Go Smart MDI system featuring Instinct sensor made by Abbott · manufacturer · 2026-01-12 — FDA clearance (12 Jan 2026) of MiniMed Go — the InPen smart pen plus the Instinct sensor in one app. Cleared for ages 7+, and 2–6 with adult supervision, for insulin-requiring type 1 and type 2 diabetes. US launch signalled for spring 2026.
  4. [4]MiniMed expands sensor portfolio in Europe with CE Mark for MiniMed 780G system with the Instinct sensor, made by Abbott · manufacturer · 2026-03-10 — CE Mark on 10 Mar 2026. EU indication is ages 2+ for type 1 and insulin-requiring type 2 diabetes, and — unlike the US label — includes pregnancy. 15-day wear vs 7 days for Guardian 4 / Simplera Sync.
  5. [5]MiniMed launches Instinct sensors in Europe giving people with diabetes more sensor choice with the same proven outcomes · manufacturer · 2026-06-23 — European rollout of Instinct and Instinct Go from 23 June 2026. MiniMed states that a randomized crossover study in Diabetes Technology & Therapeutics found 780G glycemic outcomes "virtually identical" on Instinct vs Simplera Sync, and cites real-world data from >20,000 US 780G users. No DOI or PMID for that study could be located — this is the company's characterisation of it, not a paper we have read.
  6. [6]Instinct Sensor — Consumer Guide · news — American Diabetes Association consumer guide listing for Instinct: MARD 8.2%, 15-day wear, 1-hour warm-up, no calibration, readings every 5 minutes.